Caitong International Asset Management Co., LTD Vera Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 36 shares of VERA stock, worth $764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36Holding current value
$764% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$121 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$101 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70.9 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$62.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$62 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $574M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...